NCT02064907View on ClinicalTrials.gov

Bioavailability, Safety, and Pharmacodynamics of Dexlansoprazole Delayed-Release Orally Disintegrating Tablets in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

March 31, 2014

Study Completion Date

April 30, 2014

Conditions
Bioavailability
Interventions
DRUG

Dexlansoprazole Delayed Release Orally Disintegrating Tablets

Dexlansoprazole delayed-release, orally disintegrating (OD) tablets

DRUG

Dexlansoprazole Delayed Release Capsules

Dexlansoprazole delayed-release capsules

Trial Locations (1)

85283

Tempe

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY